Croshepa 25000 IU 5ml Injection

Croshepa 25000 IU 5ml Injection contains Heparin, an anticoagulant medication used to prevent and treat blood clots.

Benefits

This injection helps prevent the formation and growth of harmful blood clots, offering crucial protection in situations with increased clotting risk. Its rapid action is valuable when immediate anticoagulation is necessary.

Uses and Indications

• Prevention and treatment of deep vein thrombosis (blood clots in leg veins).
• Prevention and treatment of pulmonary embolism (blood clots in the lungs).
• Management of acute peripheral arterial occlusion (sudden blockage of blood flow in arteries).
• Treatment of unstable angina pectoris (chest pain due to reduced blood flow to the heart).
• Prevention or treatment of mural thrombosis (blood clots forming on the inner wall of the heart).
• Prevention of clotting during certain surgical procedures, such as heart and lung operations, and during kidney dialysis.

The Croshepa 25000 IU 5ml Injection contains:

• Heparin 25000 IU (active ingredient).

Dosage and Administration

Croshepa 25000 IU 5ml Injection is administered by a healthcare professional. It is typically given via intravenous injection, intravenous infusion, or deep subcutaneous injection. The dosage is highly individualised and determined by the prescribing doctor based on the patient's condition, weight, and coagulation test results. Intramuscular injection should be avoided due to the risk of haematoma formation.

Storage and Disposal

• Store the injection below 25°C.
• Protect from light and do not freeze.
• Keep out of reach of children.
• Dispose of unused medicine according to local requirements.

Precautions and Safety

• Regular monitoring of coagulation parameters (e.g., aPTT) and platelet count is essential during heparin therapy.
• Inform your doctor about all other medications, especially those affecting blood clotting, such as aspirin, NSAIDs, or other anticoagulants, as these can increase the risk of bleeding.
• Avoid alcohol consumption as it may increase the risk of stomach bleeding.
• This medicine should not be administered intramuscularly.
• Exercise caution in patients with bleeding disorders, severe liver disease, severe hypertension, or a history of heparin-induced thrombocytopenia.

Side Effects and Risks

• The most common side effect is bleeding, which can range from mild bruising to serious or life-threatening haemorrhage.
• Other common side effects include injection site reactions such as pain, redness, or bruising.
• Less common but serious side effects include heparin-induced thrombocytopenia (HIT) and allergic reactions (e.g., rash, itching, fever, difficulty breathing).
• Report any unusual bleeding, bruising, or signs of allergic reaction to your doctor immediately.

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.